Atossa Therapeutics
ATOS
#10791
Rank
C$22.82 M
Marketcap
C$2.29
Share price
-8.86%
Change (1 day)
113.57%
Change (1 year)

EPS for Atossa Therapeutics (ATOS)

EPS in 2026 (TTM): C-$5.69

According to Atossa Therapeutics's latest financial reports the company's current EPS (TTM) is C-$5.87. In 2025 the company made an earnings per share (EPS) of C-$5.79 a decrease over its 2024 EPS that were of C-$4.36.

EPS history for Atossa Therapeutics from 2010 to 2026

Annual EPS

Year EPS Change
2026 (TTM)C-$5.69-1.82%
2025C-$5.7932.89%
2024C-$4.36-15.56%
2023C-$5.1614.29%
2022C-$4.5216.67%
2021C-$3.87-90.86%
2020C-$42.37-2.96%
2019C-$43.67-63.09%
2018C-$118.31-49.63%
2017C-$234.89-57.87%
2016C-$557.54-74.01%
2015C-$2,145-9.18%
2014C-$2,362-12.86%
2013C-$2,71070.73%
2012C-$1,58734.07%
2011C-$1,184263.41%
2010C-$325.81

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Johnson & Johnson
JNJ
C$9.58-263.32%๐Ÿ‡บ๐Ÿ‡ธ USA
Quest Diagnostics
DGX
C$14.60-348.90%๐Ÿ‡บ๐Ÿ‡ธ USA
LabCorp
LH
C$17.60-400.00%๐Ÿ‡บ๐Ÿ‡ธ USA
NeoGenomics
NEO
C-$0.36-93.89%๐Ÿ‡บ๐Ÿ‡ธ USA
Enzo Biochem
ENZB
C-$0.30-94.87%๐Ÿ‡บ๐Ÿ‡ธ USA